what is the difference between semaglutide and compounded semaglutide regular Tirzepatide vs Semaglutide: What You Need to Know Semaglutide | GoodGirlRx
Description
Important topics include: Potential drug interactions between GLP-1 medications and DMARDs Monitoring strategies for both conditions Whether weight loss might improve RA symptoms or treatment response Cardiovascular risk reduction strategies Safety considerations including contraindications (personal/family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2) Patients should not discontinue or modify DMARD therapy based on unproven theories about GLP-1 medications treating RA
Common Side Effects The most commonly reported adverse events are gastrointestinal in nature: Nausea (approximately 20-44% of participants) Diarrhea (approximately 30%) Vomiting (approximately 24%) These symptoms are typically mild to moderate in severity, tend to occur most frequently during dose escalation, and generally diminish over time as tolerance develops
Newer diabetes medications like GLP-1 receptor agonists (Ozempic, Mounjaro) seem to promote the most weight loss, while oral drugs like metformin and SGLT2 Inhibitors (Jardiance) tend to lead to more modest outcomes for weight
4 Mao X, Zhang X, Henry L, et al
these side effects often diminish as the body adjusts, though discontinuation rates were 2124% across doses
Highlights of prescribing information: Saxenda (liraglutide) injection, for subcutaneous use
